This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for treatment of diabetic foot ulcers (DFUs).